Physician profile
Ronald Royce
NPI 1831169374
$4,236.44
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $391 · 2021: $299 · 2022: $1,558 · 2023: $1,557 · 2024: $32.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,261 · Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,260.65 |
| Food and Beverage | $328.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $1,790.19 | 2020-2022 | |
| Steelhead Surgical INC | $1,013.89 | 2023-2024 | |
| Stryker Corporation | $460.05 | 2019-2021 | |
| Arthrex, INC. | $360.80 | 2023 | |
| Smith+Nephew, INC. | $176.25 | 2020-2022 | |
| Orthalign INC | $150.00 | 2023 | Orthalign Plus |
| Pacira Therapeutics, INC. | $143.69 | 2019 | |
| Bioventus LLC | $53.93 | 2022-2024 | Durolane |
| Depuy Synthes Sales INC. | $31.97 | 2023 | Corail |
| Ferring Pharmaceuticals INC. | $29.12 | 2022-2023 | Euflexxa |
| Orthofix Medical, INC. | $26.55 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$13,344.68 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Royce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.